CEFTAZIDIME QILU 2 g, poudre pour solution injectable/pour perfusion (IV) — 1 flacon en verre de 50 mL

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930146743
  • CIP7 3014674
  • CIS 67623809

What the source publishes

Holder
QILU PHARMA SPAIN (ESPAGNE)
Active ingredients
CEFTAZIDIME PENTAHYDRATÉE AVEC DU CARBONATE DE SODIUM POUR PRÉPARATIONS INJECTABLES, CEFTAZIDIME ANHYDRE
Form
poudre pour solution injectable ou pour perfusion
Package
1 flacon en verre de 50 mL
Routes
intraveineuse
Administrative status
authorised
Supply regime
prescription initiale hospitalière ; liste I
Marketing status
Déclaration de commercialisation
Authorised on
2018-04-26
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930146743
{
  "cis": "67623809",
  "cip7": "3014674",
  "form": "poudre pour solution injectable ou pour perfusion",
  "name": "CEFTAZIDIME QILU 2 g, poudre pour solution injectable/pour perfusion (IV) — 1 flacon  en verre de 50 mL",
  "cip13": "3400930146743",
  "holder": "QILU PHARMA SPAIN (ESPAGNE)",
  "routes": [
    "intraveineuse"
  ],
  "holders": [
    "QILU PHARMA SPAIN (ESPAGNE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "13.97",
  "authorisedOn": "2018-04-26",
  "compositions": [
    {
      "name": "CEFTAZIDIME PENTAHYDRATÉE AVEC DU CARBONATE DE SODIUM POUR PRÉPARATIONS INJECTABLES",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "28126",
      "dosageReference": null,
      "pharmaceuticalElement": "poudre"
    },
    {
      "name": "CEFTAZIDIME ANHYDRE",
      "nature": "FT",
      "strength": "2 g",
      "linkageNumber": "1",
      "substanceCode": "49416",
      "dosageReference": "un flacon",
      "pharmaceuticalElement": "poudre"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription initiale hospitalière ; liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "12.95",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "CEFTAZIDIME QILU 2 g, poudre pour solution injectable/pour perfusion (IV)",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 flacon  en verre de 50 mL",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2026-01-30",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CEFTAZIDIME PENTAHYDRATÉE AVEC DU CARBONATE DE SODIUM POUR PRÉPARATIONS INJECTABLES",
    "CEFTAZIDIME ANHYDRE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "prescription initiale hospitalière",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930146743"